Severe acute respiratory syndrome (SARS) is an acute respiratory disease which first appeared in 2002. Integrated Chinese and Western medicines played an important role in the treatment of SARS and this review assessed the effectiveness and safety of this integrated treatment approach. Among 5327 confirmed cases, 3104 patients received traditional Chinese medicine.
We identified 12 randomized controlled trials and one quasi-randomized controlled trial involving 654 SARS patients. Clinical evidence shows that integrated Western and Chinese medicine does not decrease the mortality rate. It is possible that different Chinese herbs combined with Western medicines may improve symptoms, quality of life, lung infiltrate absorption and decrease corticosteroid dosage. No severe adverse events were found. The evidence is weak because of the poor quality of the included trials.
